CMMRD-associated embryonic rhabdomyosarcoma in a child. Clinical case with literature review

Q4 Medicine
A. Rodina, V. Polyakov, A. Krylov, V. V. Semenova, V. M. Kozlova, T. Nasedkina, A. L. Kashanina, N. A. Kozlov, V. V. Migunova, T. Gorbunova
{"title":"CMMRD-associated embryonic rhabdomyosarcoma in a child. Clinical case with literature review","authors":"A. Rodina, V. Polyakov, A. Krylov, V. V. Semenova, V. M. Kozlova, T. Nasedkina, A. L. Kashanina, N. A. Kozlov, V. V. Migunova, T. Gorbunova","doi":"10.21682/2311-1267-2023-10-3-89-100","DOIUrl":null,"url":null,"abstract":"Introduction. Hereditary disorders in the DNA repair system can lead to the development of malignant neoplasms in childhood. DNA constitutional mismatch repair deficiency syndrome (CMMRD) is a very rare genetic autosomal recessive disorder caused by homozygous mutations in one of the four mismatch repair genes (MLH1, MSH2, MSH6, and PMS2). The frequency of occurrence is 0.0000001 of the adult and child population. For now about 150 observations have been published in the world literature. The prognosis for CMMRD syndrome is extremely unfavorable. The spectrum of tumors that make up the CMMRD syndrome is very wide, and includes mainly malignant brain tumors, tumors of the digestive tract, hematological malignancies, embryonic tumors, all of which develop in childhood.The purpose of the study is to report a case of CMMRD-associated embryonic rhabdomyosarcoma in a 3-year-old child.Conclusions. A review of the literature and the clinical case we have described show that rhabdomyosarcoma belongs to the tumor spectrum of the CMMRD syndrome. An immunohistochemical study revealed an isolated loss of PMS2 gene expression. Taking into account the clinical course of the CMMRD syndrome, a thorough study of the family history in patients with rhabdomyosarcoma is recommended, as well as a molecular genetic study, including the search for germinal mutations in genes in the DNA repair system and the assessment of microsatellite instability in the material of the tumor tissue. The clinical symptoms of CMMRD syndrome are nonspecific and depend on the morphological variant of the primary tumor. Distinctive molecular genetic features of this syndrome are: homozygous mutations with loss of function of the germline genes of the MMR system (mismatch repair) (MLH1, MSH2, MSH6 or PMS2).","PeriodicalId":52396,"journal":{"name":"Russian Journal of Pediatric Hematology and Oncology","volume":"32 14","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Russian Journal of Pediatric Hematology and Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21682/2311-1267-2023-10-3-89-100","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction. Hereditary disorders in the DNA repair system can lead to the development of malignant neoplasms in childhood. DNA constitutional mismatch repair deficiency syndrome (CMMRD) is a very rare genetic autosomal recessive disorder caused by homozygous mutations in one of the four mismatch repair genes (MLH1, MSH2, MSH6, and PMS2). The frequency of occurrence is 0.0000001 of the adult and child population. For now about 150 observations have been published in the world literature. The prognosis for CMMRD syndrome is extremely unfavorable. The spectrum of tumors that make up the CMMRD syndrome is very wide, and includes mainly malignant brain tumors, tumors of the digestive tract, hematological malignancies, embryonic tumors, all of which develop in childhood.The purpose of the study is to report a case of CMMRD-associated embryonic rhabdomyosarcoma in a 3-year-old child.Conclusions. A review of the literature and the clinical case we have described show that rhabdomyosarcoma belongs to the tumor spectrum of the CMMRD syndrome. An immunohistochemical study revealed an isolated loss of PMS2 gene expression. Taking into account the clinical course of the CMMRD syndrome, a thorough study of the family history in patients with rhabdomyosarcoma is recommended, as well as a molecular genetic study, including the search for germinal mutations in genes in the DNA repair system and the assessment of microsatellite instability in the material of the tumor tissue. The clinical symptoms of CMMRD syndrome are nonspecific and depend on the morphological variant of the primary tumor. Distinctive molecular genetic features of this syndrome are: homozygous mutations with loss of function of the germline genes of the MMR system (mismatch repair) (MLH1, MSH2, MSH6 or PMS2).
一名儿童的 CMMRD 相关胚胎横纹肌肉瘤。临床病例及文献综述
简介DNA 修复系统的遗传性疾病可导致儿童期恶性肿瘤的发生。DNA 宪制性错配修复缺陷综合征(CMMRD)是一种非常罕见的常染色体隐性遗传疾病,由四个错配修复基因(MLH1、MSH2、MSH6 和 PMS2)之一的同源突变引起。在成人和儿童群体中的发病率为 0.0000001。目前,世界文献中已发表了约 150 例观察结果。CMMRD 综合征的预后极差。构成CMMRD综合征的肿瘤范围非常广泛,主要包括恶性脑肿瘤、消化道肿瘤、血液恶性肿瘤、胚胎肿瘤,所有这些肿瘤均在儿童期发病。本研究的目的是报告一例3岁儿童CMMRD相关胚胎横纹肌肉瘤病例。文献综述和我们所描述的临床病例表明,横纹肌肉瘤属于CMMRD综合征的肿瘤谱系。免疫组化研究显示,PMS2基因表达孤立缺失。考虑到 CMMRD 综合征的临床过程,建议对横纹肌肉瘤患者的家族史进行全面研究,并进行分子遗传学研究,包括寻找 DNA 修复系统中基因的生殖突变,以及评估肿瘤组织材料中的微卫星不稳定性。CMMRD 综合征的临床症状无特异性,取决于原发肿瘤的形态变异。该综合征的分子遗传学特征是:MMR 系统(错配修复)(MLH1、MSH2、MSH6 或 PMS2)的种系基因发生同源突变并丧失功能。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Russian Journal of Pediatric Hematology and Oncology
Russian Journal of Pediatric Hematology and Oncology Medicine-Pediatrics, Perinatology and Child Health
CiteScore
0.40
自引率
0.00%
发文量
36
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信